Specialty Pharmaceuticals Industry Financials, Performance and Ratios
-
Industry Score
39.0 /100
Rank 96 out of 131 Industries -
Advance/Decline
10/12
-
No. of Companies22
-
Avg. Market Cap4,209
-
Price to Earning Ratio32.48
-
Price to Earning Growth Ratio0.16
-
Price to Book Ratio10.69
-
Return on Equity17.03
-
Return on Capital Employed-
-
Return on Assets15.08
-
Dividend yield 1 year %0.00
-
Net Profit Growth Annual YoY %90.32 %
-
Net Profit Growth Qtr YoY %4.04 %
-
Net Profit Growth Qtr QoQ %5.85 %
Show more
*All values are market cap weighted averages.
*All Financial parameters are in Million USD.
Specialty Pharmaceuticals Industry Market Breadth
- < -5%
- -2 to -5%
- 0 to -2%
- 0 to 2%
- 2 to 5%
- > 5%
Specialty Pharmaceuticals Peer comparison
Compare all stocks in Specialty Pharmaceuticals industry listed on stock exchanges
| Stock Name | 3M Price Chart | Market Cap | LTPLast Traded Price | Day High Low (%) | Week High Low (%) | Month High Low (%) | Qtr High Low(%) | 1 Year High low(%) | 3 Year High low(%) | 5 Year High low(%) | 10 Year High low(%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Usana Health Sciences Inc |
|
411.9
|
22.5
|
L
 0.1%
H
22.0
22.6
|
L
 2.7%
H
20.9
22.9
|
L
 12.7%
H
18.9
22.9
|
L
 8.3%
H
18.5
22.9
|
L
 -34.4%
H
18.5
38.3
|
L
 -59.7%
H
18.5
69.6
|
L
 -74.0%
H
18.5
107.9
|
L
 -64.1%
H
18.5
138.0
|
| Argen X SE (ADR) |
|
50,418.9
|
814.7
|
L
 -1.5%
H
810.5
833.8
|
L
 1.8%
H
781.1
833.8
|
L
 -4.1%
H
770.7
855.4
|
L
 -0.3%
H
749.8
934.6
|
L
 25.6%
H
510.1
934.6
|
L
 113.0%
H
327.7
934.6
|
L
 162.0%
H
248.2
934.6
|
L
H
17.3
934.6
|
| Biondvax Pharma Ltd (ADR) |
|
-
|
1
|
L
 22.0%
H
0.8
1.0
|
L
 16.3%
H
0.8
1.0
|
L
 33.3%
H
0.6
1.0
|
L
 -31.5%
H
0.6
1.6
|
L
 -65.6%
H
0.6
6.2
|
L
 -62.7%
H
0.6
6.2
|
L
 -98.3%
H
0.6
99
|
L
 -97.3%
H
0.6
620
|
| Niagen Bioscience Inc |
|
479.6
|
6.0
|
L
 -4.3%
H
6.0
6.3
|
L
 -2.9%
H
6.0
6.4
|
L
 -9.1%
H
6.0
6.9
|
L
 -20.6%
H
6.0
8.0
|
L
 1.0%
H
5.3
14.7
|
L
 216.3%
H
1.3
14.7
|
L
 22.7%
H
1.2
23.7
|
L
 46.2%
H
1.2
23.7
|
| Cronos Grp Inc |
|
1,064.4
|
2.8
|
L
 3.7%
H
2.7
2.8
|
L
 9.9%
H
2.5
2.8
|
L
 1.5%
H
2.5
2.8
|
L
 10.3%
H
2.3
3.4
|
L
 46.3%
H
1.6
3.4
|
L
 13.5%
H
1.6
3.4
|
L
 -73.9%
H
1.6
15.8
|
L
H
0.2
25.1
|
| Enveric Biosciences Inc |
|
4.3
|
4.2
|
L
 -0.7%
H
4.2
4.3
|
L
 7.9%
H
3.8
4.3
|
L
 -8.8%
H
3.5
4.6
|
L
 -43.9%
H
3.5
13.3
|
L
 -92.5%
H
3.5
59.4
|
L
 -99.2%
H
3.5
1256.4
|
L
 -100.0%
H
3.5
63000
|
L
 -100.0%
H
3.5
12150000
|
| Flora Growth Corp |
|
7.0
|
6.7
|
L
 -1.8%
H
6.5
7.4
|
L
 2.0%
H
6.1
7.4
|
L
 -9.0%
H
5.9
8.1
|
L
 -49.6%
H
5.9
13.7
|
L
 -80.1%
H
5.9
47
|
L
 -96.8%
H
5.9
464.3
|
L
H
5.9
16731
|
L
H
5.9
16731
|
| IM Cannabis Corp |
|
7.1
|
1.4
|
L
 -0.7%
H
1.3
1.4
|
L
 -2.2%
H
1.3
1.5
|
L
 -8.8%
H
1.3
1.6
|
L
 -9.4%
H
0.9
2.1
|
L
 -38.9%
H
0.9
7.1
|
L
 -83.5%
H
0.4
11.0
|
L
 -99.7%
H
0.4
697.8
|
L
H
0.4
697.8
|
| Lifevantage Corp |
|
78.0
|
6.1
|
L
 2.9%
H
6.0
6.2
|
L
 -3.2%
H
5.5
6.5
|
L
 -3%
H
5.5
6.8
|
L
 -29.2%
H
5.5
8.9
|
L
 -74.7%
H
5.5
24.7
|
L
 60.3%
H
3.0
27.4
|
L
 -33.7%
H
3.0
27.4
|
L
 -24.5%
H
2.9
27.4
|
| Mannatech Inc |
|
14.6
|
7.7
|
L
 1.7%
H
7.5
7.8
|
L
 1.1%
H
7.2
7.8
|
L
 -1.9%
H
6.9
9.5
|
L
 -15.0%
H
6.9
12.5
|
L
 -37.2%
H
6.9
16.5
|
L
 -51.6%
H
6.8
21.2
|
L
 -60.0%
H
6.8
49.1
|
L
 -55.0%
H
6.5
49.1
|
| Natural Alternatives Intl Inc |
|
25.6
|
4.2
|
L
 -3.9%
H
4.0
4.3
|
L
 -11.7%
H
4.0
4.8
|
L
 29.3%
H
3.2
5.0
|
L
 52.6%
H
2.7
5.0
|
L
 -1.9%
H
2.6
5.0
|
L
 -52.6%
H
2.6
9.7
|
L
 -68.0%
H
2.6
19.9
|
L
 -46.9%
H
2.6
19.9
|
| Nature`s Sunshine Products Inc |
|
431.6
|
24.7
|
L
 0.5%
H
24.4
24.8
|
L
 2.5%
H
23.0
24.8
|
L
 13.0%
H
20.9
24.8
|
L
 75.0%
H
13.0
24.8
|
L
 70.8%
H
11.0
24.8
|
L
 153.8%
H
8.3
24.8
|
L
 52.8%
H
7.9
24.8
|
L
 171.4%
H
5.5
24.8
|
| Paranovus Entertainment Tech Ltd (Class A) |
|
6.4
|
1.8
|
L
 -6.7%
H
1.8
1.9
|
L
 -6.2%
H
1.7
2.0
|
L
 14.6%
H
1.6
3.0
|
L
 -97.0%
H
1.4
120
|
L
 -98.7%
H
1.4
150
|
L
 -99.7%
H
1.4
670
|
L
 -100.0%
H
1.4
5160
|
L
H
1.4
12200
|
| PharmaCyte Biotech Inc |
|
9.5
|
0.9
|
L
 4.4%
H
0.9
1.0
|
L
 5.6%
H
0.8
1.0
|
L
 23.7%
H
0.7
1.0
|
L
 -4.1%
H
0.6
1.5
|
L
 -42.3%
H
0.6
1.9
|
L
 -67.7%
H
0.6
3.2
|
L
 -96.4%
H
0.6
55.5
|
L
 -99.0%
H
0.6
253.4
|
| AIxCrypto Holdings Inc |
|
11.0
|
2.1
|
L
H
2.1
2.2
|
L
 -7.8%
H
2.1
2.4
|
L
 -20.7%
H
2.1
2.9
|
L
 -41.2%
H
2.1
3.4
|
L
 -49.7%
H
1.6
8.8
|
L
 -96.7%
H
0.1
74
|
L
 -99.9%
H
0.1
2217
|
L
 -100.0%
H
0.1
468750
|
| Revolution Medicines Inc |
|
22,740.2
|
117.6
|
L
 -1.0%
H
117.6
120.6
|
L
 -2.2%
H
114.0
120.6
|
L
 44.9%
H
76.3
124.5
|
L
 115.9%
H
55.4
124.5
|
L
 187.0%
H
29.2
124.5
|
L
 320.6%
H
15.5
124.5
|
L
 172.5%
H
14.1
124.5
|
L
H
14.1
124.5
|
| Upexi Inc |
|
126.4
|
2
|
L
 1.0%
H
1.9
2.0
|
L
 -13.4%
H
1.9
2.2
|
L
 5.3%
H
1.7
2.5
|
L
 -59.3%
H
1.7
5.3
|
L
 -53.3%
H
1.7
22.5
|
L
 -96.6%
H
1.7
98.8
|
L
H
1.7
187.4
|
L
H
1.7
187.4
|
| Scinai Immunotherapeutics Ltd (ADR) |
|
3.5
|
1
|
L
 22.0%
H
0.8
1.0
|
L
 16.3%
H
0.8
1.0
|
L
 33.3%
H
0.6
1.0
|
L
 -31.5%
H
0.6
1.6
|
L
 -71.4%
H
0.6
6.2
|
L
 -96.3%
H
0.6
46.9
|
L
 -99.8%
H
0.6
637
|
L
 -99.7%
H
0.6
6200
|
| FitLife Brands Inc |
|
147.9
|
15.8
|
L
 -4.4%
H
15.8
16.4
|
L
 -0.5%
H
15.7
16.9
|
L
 -2.0%
H
15.0
16.9
|
L
 -18.4%
H
15.0
20.0
|
L
 -50.3%
H
9.8
33.5
|
L
 -4.8%
H
9.8
35.5
|
L
 -4.8%
H
9.8
35.5
|
L
 -4.8%
H
9.8
35.5
|
| Abivax (ADR) |
|
9,579.6
|
122.1
|
L
 -1.2%
H
122
125.9
|
L
 4.3%
H
113.6
125.9
|
L
 -16.0%
H
109.0
147
|
L
 34.6%
H
90.9
148.8
|
L
 1905.3%
H
4.8
148.8
|
L
H
4.8
148.8
|
L
H
4.8
148.8
|
L
H
4.8
148.8
|
| Synergy CHC Corp |
|
20.9
|
1.9
|
L
 -2.1%
H
1.9
1.9
|
L
 3.3%
H
1.7
2.0
|
L
 0.5%
H
1.7
2.0
|
L
 -24.4%
H
1.7
2.6
|
L
 -50%
H
1.3
4.5
|
L
H
1.3
4.6
|
L
H
1.3
4.6
|
L
H
1.3
4.6
|
| iBio Inc |
|
50.6
|
2.3
|
L
 -5.9%
H
2.3
2.5
|
L
 2.3%
H
2.1
2.5
|
L
 20.3%
H
1.7
2.9
|
L
 86.0%
H
1.0
3.8
|
L
 181.3%
H
0.6
3.8
|
L
 181.3%
H
0.6
3.8
|
L
 181.3%
H
0.6
3.8
|
L
 181.3%
H
0.6
3.8
|